# Novavax Inc: Form 8-K, filed Mar 11, 2025

- Company: [Novavax Inc](/companies/nvax.md) (CIK 1000694)
- Form: 8-K
- Filed: 2025-03-11
- Accepted by EDGAR: Mar 11, 2025, 08:30 ET
- Period: 2025-03-07
- Accession: 0001104659-25-022435
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1000694/000110465925022435/tm258808d2_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1000694/000110465925022435/

## Items reported

- Item 1.02: Termination of a material agreement

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1000694/000110465925022435/tm258808d2_8k.htm

Filed Mar 11, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-022435. Last ingested by Listed: Nov 10, 2026, 17:20 ET. No prices; not investment advice.
